Steven Cohen’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-307,355
| Closed | -$12.2M | – | 4086 |
|
|
2026
Q1 | $12.2M | Buy |
+307,355
| New | +$7.86M | 0.02% | 1107 |
|
|
2025
Q4 | – | Sell |
-1,072,665
| Closed | -$26M | – | 3940 |
|
|
2025
Q3 | $26M | Sell |
1,072,665
-1,518,931
| -59% | -$27M | 0.04% | 465 |
|
|
2025
Q2 | $34.1M | Buy |
2,591,596
+305,163
| +13% | +$3.87M | 0.07% | 332 |
|
|
2025
Q1 | $32.9M | Sell |
2,286,433
-1,140,166
| -33% | -$18.7M | 0.08% | 312 |
|
|
2024
Q4 | $57.4M | Buy |
3,426,599
+710,936
| +26% | +$11.8M | 0.13% | 189 |
|
|
2024
Q3 | $43.4M | Buy |
2,715,663
+953,659
| +54% | +$11.7M | 0.11% | 214 |
|
|
2024
Q2 | $15.9M | Sell |
1,762,004
-495,714
| -22% | -$4.7M | 0.04% | 457 |
|
|
2024
Q1 | $25.5M | Buy |
2,257,718
+417,236
| +23% | +$3.95M | 0.06% | 371 |
|
|
2023
Q4 | $14.7M | Hold |
1,840,482
| – | – | 0.04% | 551 |
|
|
2023
Q3 | $11.9M | Sell |
1,840,482
-170,906
| -8% | -$1.17M | 0.03% | 585 |
|
|
2023
Q2 | $12.5M | Buy |
2,011,388
+235,906
| +13% | +$1.12M | 0.04% | 523 |
|
|
2023
Q1 | $6.84M | Buy |
1,775,482
+1,695,782
| +2,128% | +$6.2M | 0.02% | 668 |
|
|
2022
Q4 | $247K | Sell |
79,700
-38,100
| -32% | -$141K | ﹤0.01% | 1237 |
|
|
2022
Q3 | $474K | Sell |
117,800
-15,800
| -12% | -$72.3K | ﹤0.01% | 1177 |
|
|
2022
Q2 | $651K | Sell |
133,600
-773,400
| -85% | -$4.95M | ﹤0.01% | 1150 |
|
|
2022
Q1 | $8.14M | Sell |
907,000
-190,908
| -17% | -$1.74M | 0.03% | 572 |
|
|
2021
Q4 | $12.4M | Buy |
1,097,908
+795,708
| +263% | +$10.7M | 0.05% | 452 |
|
|
2021
Q3 | $5.05M | Buy |
302,200
+202,200
| +202% | +$4.18M | 0.02% | 661 |
|
|
2021
Q2 | $2.22M | Buy |
+100,000
| New | +$2.35M | 0.01% | 720 |
|
Steven Cohen's CNTA Position: Q2 2026 in Review
Steven Cohen sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 307,355 shares — an estimated $12.2M sold.
Steven Cohen first reported a position in CNTA in Q2 2021 and held it in 19 quarters. The position peaked at $57.4M in Q4 2024. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.
- Steven Cohen reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Steven Cohen sold 307,355 Centessa Pharmaceuticals shares in Q2 2026, an estimated $12.2M.
- Steven Cohen first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 19 quarters.
- Steven Cohen's Centessa Pharmaceuticals position peaked at $57.4M in Q4 2024.
- 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.